Wanbangde Pharmaceutical Holding Group Co Ltd Financial Flexibility Index
Wanbangde Pharmaceutical Holding Group Co Ltd financial flexibility index. Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥144.78 Million (operating CF CN¥-1.04 Million minus capex CN¥145.81 Million) represents 0% of total liabilities (CN¥1.78 Billion). Explore how much does Wanbangde Pharmaceutical Holding Group C reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)
Financial flexibility index of Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2025. Historical Financial Flexibility Index trend for Wanbangde Pharmaceutical Holding Group Co Ltd across 23 annual periods. Check 002082 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Wanbangde Pharmaceutical Holding Group Co Ltd Financial Flexibility Index by Year (2003–2025)
Wanbangde Pharmaceutical Holding Group Co Ltd financial flexibility index by year from 2003 to 2025. Year-by-year free cash flow to debt coverage for Wanbangde Pharmaceutical Holding Group Co Ltd. For the full cash flow conversion analysis, see Wanbangde Pharmaceutical Holding Group C (002082) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | CN¥893.63 Million | CN¥603.98 Million | CN¥1.78 Billion | ▲ +277.2% |
| 2024 | 0.13x | CN¥208.65 Million | CN¥120.22 Million | CN¥1.57 Billion | ▲ +265.6% |
| 2023 | 0.04x | CN¥55.85 Million | CN¥-72.87 Million | CN¥1.54 Billion | ▲ +170.1% |
| 2022 | -0.05x | CN¥-72.42 Million | CN¥-239.65 Million | CN¥1.40 Billion | ▼ -128.2% |
| 2021 | 0.18x | CN¥299.14 Million | CN¥22.09 Million | CN¥1.63 Billion | ▼ -27.4% |
| 2020 | 0.25x | CN¥710.25 Million | CN¥151.01 Million | CN¥2.80 Billion | ▲ +204.1% |
| 2019 | 0.08x | CN¥157.29 Million | CN¥-248.69 Million | CN¥1.89 Billion | ▼ -72.1% |
| 2018 | 0.30x | CN¥335.03 Million | CN¥135.40 Million | CN¥1.12 Billion | ▲ +4424.1% |
| 2017 | 0.01x | CN¥3.28 Million | CN¥-17.60 Million | CN¥496.58 Million | ▼ -99.5% |
| 2016 | 1.22x | CN¥319.74 Million | CN¥310.71 Million | CN¥261.85 Million | ▲ +598.8% |
| 2015 | 0.17x | CN¥47.23 Million | CN¥16.76 Million | CN¥270.28 Million | ▼ -76.0% |
| 2014 | 0.73x | CN¥185.22 Million | CN¥140.31 Million | CN¥254.69 Million | ▲ +6.4% |
| 2013 | 0.68x | CN¥246.80 Million | CN¥234.35 Million | CN¥361.07 Million | ▲ +31.6% |
| 2012 | 0.52x | CN¥243.65 Million | CN¥202.73 Million | CN¥469.09 Million | ▲ +53.3% |
| 2011 | 0.34x | CN¥132.86 Million | CN¥-1.44 Million | CN¥392.22 Million | ▼ -37.5% |
| 2010 | 0.54x | CN¥206.29 Million | CN¥162.26 Million | CN¥380.46 Million | ▲ +30.1% |
| 2009 | 0.42x | CN¥128.15 Million | CN¥68.13 Million | CN¥307.39 Million | ▼ -67.7% |
| 2008 | 1.29x | CN¥399.99 Million | CN¥253.06 Million | CN¥309.46 Million | ▲ +442.4% |
| 2007 | 0.24x | CN¥122.13 Million | CN¥12.45 Million | CN¥512.51 Million | ▲ +21.4% |
| 2006 | 0.20x | CN¥96.97 Million | CN¥3.50 Million | CN¥493.85 Million | ▲ +0.8% |
| 2005 | 0.19x | CN¥99.08 Million | CN¥11.23 Million | CN¥508.84 Million | ▼ -58.3% |
| 2004 | 0.47x | CN¥130.99 Million | CN¥32.69 Million | CN¥280.48 Million | ▲ +1.6% |
| 2003 | 0.46x | CN¥74.93 Million | CN¥37.01 Million | CN¥163.05 Million | — |